Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 12 studies | 32% ± 13% | |
astrocyte | 9 studies | 39% ± 18% | |
oligodendrocyte | 9 studies | 30% ± 10% | |
oligodendrocyte precursor cell | 8 studies | 34% ± 15% | |
glutamatergic neuron | 7 studies | 46% ± 23% | |
GABAergic neuron | 6 studies | 38% ± 19% | |
endothelial cell | 5 studies | 29% ± 2% | |
adipocyte | 5 studies | 21% ± 4% | |
cardiac muscle cell | 4 studies | 25% ± 1% | |
fibroblast | 4 studies | 21% ± 7% | |
interneuron | 4 studies | 42% ± 23% | |
microglial cell | 3 studies | 19% ± 3% | |
epithelial cell | 3 studies | 24% ± 6% | |
ependymal cell | 3 studies | 43% ± 15% | |
granule cell | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 577.54 | 2636 / 2642 | 98% | 4.46 | 694 / 705 |
thymus | 100% | 650.58 | 653 / 653 | 91% | 2.44 | 549 / 605 |
adrenal gland | 99% | 517.34 | 256 / 258 | 90% | 2.92 | 207 / 230 |
kidney | 99% | 318.67 | 88 / 89 | 90% | 2.84 | 812 / 901 |
prostate | 100% | 382.63 | 244 / 245 | 81% | 1.67 | 405 / 502 |
breast | 99% | 328.67 | 453 / 459 | 81% | 2.26 | 906 / 1118 |
lung | 98% | 409.28 | 567 / 578 | 73% | 1.66 | 839 / 1155 |
esophagus | 98% | 300.39 | 1419 / 1445 | 67% | 1.42 | 122 / 183 |
uterus | 100% | 461.29 | 170 / 170 | 52% | 1.09 | 239 / 459 |
skin | 95% | 176.47 | 1719 / 1809 | 56% | 1.10 | 262 / 472 |
stomach | 97% | 222.01 | 347 / 359 | 42% | 0.85 | 119 / 286 |
bladder | 95% | 245.57 | 20 / 21 | 42% | 0.87 | 212 / 504 |
pancreas | 75% | 97.59 | 247 / 328 | 62% | 1.13 | 110 / 178 |
intestine | 98% | 260.92 | 947 / 966 | 37% | 0.90 | 196 / 527 |
ovary | 100% | 559.17 | 180 / 180 | 28% | 0.49 | 122 / 430 |
liver | 88% | 117.04 | 199 / 226 | 17% | 0.28 | 69 / 406 |
spleen | 100% | 288.22 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 387.26 | 1329 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 269.23 | 792 / 803 | 0% | 0 | 0 / 0 |
adipose | 97% | 252.60 | 1169 / 1204 | 0% | 0 | 0 / 0 |
heart | 96% | 427.59 | 825 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 40% | 0.79 | 32 / 80 |
tonsil | 0% | 0 | 0 / 0 | 38% | 0.64 | 17 / 45 |
peripheral blood | 20% | 63.06 | 184 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.17 | 3 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | CAPS2 |
Protein name | CAPS2 protein Calcyphosine 2 Calcyphosin-2 (Calcyphosine-2) |
Synonyms | UG0636c06 |
Description | |
Accessions | ENST00000409445.8 [Q9BXY5-1] ENST00000336815.10 A2RRN2 F8VZC3 ENST00000551829.5 F8VWP7 ENST00000552497.5 C9J524 Q9BXY5 ENST00000436898.6 F8W927 ENST00000393284.8 [Q9BXY5-5] ENST00000699294.1 [Q9BXY5-4] H7BXT1 B9A061 ENST00000328705.7 ENST00000409799.6 |